Metis TechBio inks up to $1.1 billion deal with Eli Lilly for drug delivery tech
LLY•Metis TechBio entered a collaboration with Eli Lilly worth up to $1.1 billion to research and develop tissue-specific drug delivery technologies.
LLY•LLY•LLY•Metis TechBio entered a collaboration with Eli Lilly worth up to $1.1 billion to research and develop tissue-specific drug delivery technologies.
Metis TechBio said it entered a collaboration agreement with Eli Lilly worth up to $1.1 billion for research and development of tissue-specific drug delivery technologies.
